BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/12/2014 8:41:00 PM | Browse: 804 | Download: 907
Publication Name World Journal of Gastroenterology
Manuscript ID 4436
Country China
Received
2013-06-29 19:43
Peer-Review Started
2013-06-29 21:12
To Make the First Decision
2013-08-21 18:34
Return for Revision
2013-08-22 19:03
Revised
2013-09-10 01:16
Second Decision
2013-09-29 11:17
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2013-09-29 21:59
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
2013-10-15 14:18
Typeset the Manuscript
2013-11-04 10:38
Publish the Manuscript Online
2013-11-18 10:59
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Autobiography
Article Title Radiofrequency ablation of hepatocellular carcinoma sized > 3 and ≤ 5 cm: Is ablative margin of more than 1 cm justified?
Manuscript Source Invited Manuscript
All Author List Shan Ke, Xue-Mei Ding, Xiao-Jun Qian, Yi-Ming Zhou, Bao-Xin Cao, Kun Gao and Wen Bing Sun
Funding Agency and Grant Number
Funding Agency Grant Number
National Natural Science Foundation of China 30872490
National Natural Science Foundation of China 81172320
Dr. Wu Jie-Ping Medical Foundation 320675012712
Dr. Wu Jie-Ping Medical Foundation 320675007131
Corresponding Author Wen-Bing Sun, MD, PhD, Department of Hepatobiliary Surgery, Chao-yang Hospital Affiliated to Capital Medical University, Beijing Gongren Tiyuchang Nan Road No. 8, Beijing 100043, China. cyhswb@qq.com
Key Words Hepatocellular carcinoma; Radiofrequency ablation; Ablative margin; Recurrence; Survival
Core Tip Recurrence is the most important factor for prognosis of hepatocellular carcinoma (HCC) after radiofrequency ablation. Although a sufficient ablative margin (AM) is an essential way to minimize recurrence risk, the optimal AM for HCC tumors 3.1 to 5.0 cm remains controversial. This study provides evidence that, for HCC tumors 3.1 to 5.0 cm, AMs > 1.0 cm could reduce chance of recurrence compared to AMs of 0.5-1.0 cm, which emphasizes the need for more strategic AMs that are > 1.0 cm for ablation of HCC tumors of 3.1 to 5.0 cm.
Publish Date 2013-11-18 10:59
Citation Ke S, Ding XM, Qian XJ, Zhou YM, Cao BX, Gao K, Sun WB. Radiofrequency ablation of hepatocellular carcinoma sized > 3 and ≤ 5 cm: Is ablative margin of more than 1 cm justified? World J Gastroenterol 2013; 19(42): 7389-7398
URL http://www.wjgnet.com/1007-9327/full/v19/i42/7389.htm
DOI http://dx.doi.org/10.3748/wjg.v19.i42.7389
Full Article (PDF) WJG-19-7389.pdf
Manuscript File 4436-Review.doc
Answering Reviewers 4436-Answering reviewers.pdf
Copyright License Agreement 4436-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate 4436-Language certificate.pdf
Peer-review Report 4436-Peer review(s).pdf
Scientific Editor Work List 4436-Scientific editor work list.doc